Cargando…
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961761/ https://www.ncbi.nlm.nih.gov/pubmed/29904588 http://dx.doi.org/10.12688/f1000research.13284.1 |
_version_ | 1783324774554927104 |
---|---|
author | Culyer, Anthony Chalkidou, Kalipso Teerawattananon, Yot Santatiwongchai, Benjarin |
author_facet | Culyer, Anthony Chalkidou, Kalipso Teerawattananon, Yot Santatiwongchai, Benjarin |
author_sort | Culyer, Anthony |
collection | PubMed |
description | There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal perspective is “societal”. In this paper we endorse the first principle but dissent from the second. A review of recommended perspectives is presented. The societal perspective is frequently not the one recommended. The societal perspective is shown to be less comprehensive than is commonly supposed, is inappropriate in many contexts and, in any case, is in general not a perspective to be determined independently of the context of a decision problem. Moreover, the selection of a perspective, societal or otherwise, is not the prerogative of analysts. |
format | Online Article Text |
id | pubmed-5961761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-59617612018-06-13 Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? Culyer, Anthony Chalkidou, Kalipso Teerawattananon, Yot Santatiwongchai, Benjarin F1000Res Opinion Article There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal perspective is “societal”. In this paper we endorse the first principle but dissent from the second. A review of recommended perspectives is presented. The societal perspective is frequently not the one recommended. The societal perspective is shown to be less comprehensive than is commonly supposed, is inappropriate in many contexts and, in any case, is in general not a perspective to be determined independently of the context of a decision problem. Moreover, the selection of a perspective, societal or otherwise, is not the prerogative of analysts. F1000 Research Limited 2018-01-17 /pmc/articles/PMC5961761/ /pubmed/29904588 http://dx.doi.org/10.12688/f1000research.13284.1 Text en Copyright: © 2018 Culyer A et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Article Culyer, Anthony Chalkidou, Kalipso Teerawattananon, Yot Santatiwongchai, Benjarin Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title | Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title_full | Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title_fullStr | Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title_full_unstemmed | Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title_short | Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? |
title_sort | rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. who decides? who pays? |
topic | Opinion Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961761/ https://www.ncbi.nlm.nih.gov/pubmed/29904588 http://dx.doi.org/10.12688/f1000research.13284.1 |
work_keys_str_mv | AT culyeranthony rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays AT chalkidoukalipso rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays AT teerawattananonyot rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays AT santatiwongchaibenjarin rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays |